Skip to content

Research at St Andrews

Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease

Research output: Contribution to journalArticle

Author(s)

Luís Gaspar, Ross P. Coron, Paul Kongthoo Lin, David M. Costa, Begoña Perez-Cabezas, Joana Tavares, Meritxell Roura-Ferrer, Isbaal Ramos, Céline Ronin, Louise L. Major, Fabrice Ciesielski, Iain K. Pemberton, Jane MacDougall, Paola Ciapetti, Terry K. Smith, Anabela Cordeiro-da-Silva

School/Research organisations

Abstract

Chagas disease remains one of the most neglected diseases in the world despite being the most important parasitic disease in Latin America. The characteristic chronic manifestation of chagasic cardiomyopathy is the region’s leading cause of heart-related illness, causing significant mortality and morbidity. Due to the limited available therapeutic options, new drugs are urgently needed to control the disease. Sirtuins, also called Silent information regulator 2 (Sir2) proteins have long been suggested as interesting targets to treat different diseases, including parasitic infections. Recent studies on Trypanosoma cruzi sirtuins have hinted at the possibility to exploit these enzymes as a possible drug targets. In the present work, the T. cruzi Sir2 related protein 1 (TcSir2rp1) is genetically validated as a drug target and biochemically characterized for its NAD+-dependent deacetylase activity and its inhibition by the classic sirtuin inhibitor nicotinamide, as well as by bisnaphthalimidopropyl (BNIP) derivatives, a class of parasite sirtuin inhibitors. BNIPs ability to inhibit TcSir2rp1, and anti-parasitic activity against T. cruzi amastigotes in vitro were investigated. The compound BNIP Spermidine (BNIPSpd) (9), was found to be the most potent inhibitor of TcSir2rp1. Moreover, this compound showed altered trypanocidal activity against TcSir2rp1 overexpressing epimastigotes and anti-parasitic activity similar to the reference drug benznidazole against the medically important amastigotes, while having the highest selectivity index amongst the compounds tested. Unfortunately, BNIPSpd failed to treat a mouse model of Chagas disease, possibly due to its pharmacokinetic profile. Medicinal chemistry modifications of the compound, as well as alternative formulations may improve activity and pharmacokinetics in the future. Additionally, an initial TcSIR2rp1 model in complex with p53 peptide substrate was obtained from low resolution X-ray data (3.5 Å) to gain insight into the potential specificity of the interaction with the BNIP compounds. In conclusion, the search for TcSir2rp1 specific inhibitors may represent a valuable strategy for drug discovery against T. cruzi.
Close

Details

Original languageEnglish
Article numbere0006180
Number of pages30
JournalPLoS Neglected Tropical Diseases
Volume12
Issue number1
DOIs
Publication statusPublished - 22 Jan 2018

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Novel benzothiazole-based ureas as 17β-HSD10 inhibitors, a potential Alzheimer’s disease treatment

    Aitken, L., Benek, O., McKelvie, B., Hughes, R. E., Hroch, L., Schmidt, M., Major, L. L., Vinklarova, L., Kuca, K., Smith, T. K., Musilek, K. & Gunn-Moore, F. J., 29 Jul 2019, In : Molecules. 24, 15, 2757.

    Research output: Contribution to journalArticle

  2. Trypanosoma brucei bloodstream forms depend upon uptake of myo-inositol for Golgi phosphatidylinositol synthesis and normal cell growth

    González-Salgado, A., Steinmann, M., Major, L. L., Sigel, E., Reymond, J-L., Smith, T. K. & Bütikofer, P., Jun 2015, In : Eukaryotic Cell. 14, 6, p. 616-624

    Research output: Contribution to journalArticle

  3. The essential roles of cytidine diphosphate-diacylglycerol synthase in bloodstream form Trypanosoma brucei

    Lilley, A. C., Major, L. L., Young, S., Stark, M. J. R. & Smith, T. K., May 2014, In : Molecular Microbiology. 92, 3, p. 453-470 18 p.

    Research output: Contribution to journalArticle

  4. Coupled Enzyme Activity and Thermal Shift Screening of the Maybridge Rule of 3 Fragment Library Against Trypanosoma brucei Choline Kinase; A Genetically Validated Drug Target.

    Major, L. L., Denton, H. & Smith, T. K., 2013, Drug Discovery. El-Shemy, H. (ed.). London: IntechOpen, p. 413-431

    Research output: Chapter in Book/Report/Conference proceedingChapter

  5. Synthesis and biological evaluation of CTP synthetase inhibitors as potential agents for the treatment of African trypanosomiasis

    Tamborini, L., Pinto, A., Smith, T. K., Major, L. L., Iannuzzi, M. C., Cosconati, S., Marinelli, L., Novellino, E., Lo Presti, L., Wong, P. E., Barrett, M. P., De Micheli, C. & Conti, P., Sep 2012, In : ChemMedChem. 7, 9, p. 1623-1634 12 p.

    Research output: Contribution to journalArticle

Related by journal

  1. PLoS Neglected Tropical Diseases (Journal)

    Simon Young (Reviewer)
    9 Oct 2017 → …

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

  2. PLoS Neglected Tropical Diseases (Journal)

    Terry K Smith (Member of editorial board)
    2015 → …

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

  3. PLoS Neglected Tropical Diseases (Journal)

    Simon Young (Reviewer)
    9 Aug 201114 Dec 2011

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

Related by journal

  1. Hepatitis B virus infection as a neglected tropical disease

    O’Hara, G. A., McNaughton, A. L., Maponga, T., Jooste, P., Ocama, P., Chilengi, R., Mokaya, J., Liyayi, M. I., Wachira, T., Gikungi, D. M., Burbridge, L., O’Donnell, D., Akiror, C. S., Sloan, D., Torimiro, J., Yindom, L. M., Walton, R., Andersson, M., Marsh, K., Newton, R. & 1 others, Matthews, P. C., 5 Oct 2017, In : PLoS Neglected Tropical Diseases. 11, 10, e0005842.

    Research output: Contribution to journalArticle

  2. Photo-affinity labelling and biochemical analyses identify the target of trypanocidal simplified natural product analogues

    Tulloch, L. B., Menzies, S. K., Fraser, A. L., Gould, E. R., King, E. F., Zacharova, M. K., Florence, G. J. & Smith, T. K., 5 Sep 2017, In : PLoS Neglected Tropical Diseases. 11, 9, 28 p., e0005886.

    Research output: Contribution to journalArticle

  3. Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana

    Mwenechanya, R., Kovářová, J., Dickens, N. J., Mudaliar, M., Herzyk, P., Vincent, I. M., Weidt, S. K., Burgess, K. E., Burchmore, R. J. S., Pountain, A. W., Smith, T. K., Creek, D. J., Kim, D-H., Lepesheva, G. I. & Barrett, M. P., 16 Jun 2017, In : PLoS Neglected Tropical Diseases. 11, 6, 21 p., e0005649.

    Research output: Contribution to journalArticle

  4. Different mutations in a P-type ATPase transporter in Leishmania parasites are associated with cross-resistance to two leading drugs by distinct mechanisms

    Fernandez-Prada, C., Vincent, I. M., Brotherton, M-C., Roberts, M., Roy, G., Rivas, L., Leprohon, P., Smith, T. K. & Ouellette, M., 2 Dec 2016, In : PLoS Neglected Tropical Diseases. 10, 12, 20 p., e0005171.

    Research output: Contribution to journalArticle

ID: 252276932

Top